HIF-2α Mutated Cancers trials recruiting in New York

Fewer than 3 recruiting trials found.

All HIF-2α Mutated Cancers trials nationally

1

Recruiting in New York

1

Cities with sites

Cities in New York

New York 1

Recruiting trials in New York

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
NCT04924075 · Phase: Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · New York: New York

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.